Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 4
1985 6
1986 2
1987 2
1988 4
1989 3
1990 1
1991 5
1992 4
1993 3
1994 3
1995 8
1996 9
1997 4
1998 4
1999 1
2000 6
2001 5
2002 8
2003 8
2004 9
2005 11
2006 13
2007 14
2008 19
2009 26
2010 28
2011 26
2012 23
2013 21
2014 16
2015 12
2016 18
2017 14
2018 7
2019 6
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
Pan Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, Symmons DPM, Lunt M, Young A; BSRBR-RA Control Centre Consortium; Hyrich KL, Verstappen SMM. Pan Y, et al. Among authors: symmons dpm. PLoS One. 2020 Apr 2;15(4):e0231481. doi: 10.1371/journal.pone.0231481. eCollection 2020. PLoS One. 2020. PMID: 32240271 Free PMC article.
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Chadwick L, Kearsley-Fleet L, Brown N; BSRBR-RA Control Centre consortium; BSRBR-RA Contributors Group; Watson KD, Lunt M, Symmons DPM, Hyrich KL. Chadwick L, et al. Among authors: symmons dpm. Rheumatology (Oxford). 2020 Mar 1;59(3):559-567. doi: 10.1093/rheumatology/kez277. Rheumatology (Oxford). 2020. PMID: 31722431
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.
Agca R, Heslinga SC, Rollefstad S, Heslinga S, Södergren A, Semb AG, Kitas GD, Sattar N, Nurmohamed MT; EULAR task force “EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update”. Agca R, et al. Ann Rheum Dis. 2020 Sep;79(9):e105. doi: 10.1136/annrheumdis-2019-215748. Epub 2019 Aug 14. Ann Rheum Dis. 2020. PMID: 31413003 No abstract available.
Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.
Pan Y, Norton S, Gwinnutt JM, Kearsley-Fleet L, Symmons DPM, Lunt M, Young A; BSRBR-RA Control Centre Consortium; Hyrich KL, Verstappen SMM. Pan Y, et al. Among authors: symmons dpm. PLoS One. 2019 May 20;14(5):e0215999. doi: 10.1371/journal.pone.0215999. eCollection 2019. PLoS One. 2019. PMID: 31107887 Free PMC article.
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.
Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF, Symmons DPM; TRACE RA Consortium. Kitas GD, et al. Among authors: symmons dpm. Arthritis Rheumatol. 2019 Sep;71(9):1437-1449. doi: 10.1002/art.40892. Epub 2019 Jul 22. Arthritis Rheumatol. 2019. PMID: 30983166 Free PMC article. Clinical Trial.
Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.
Fagerli KM, Kearsley-Fleet L, Mercer LK, Watson K, Packham J, Symmons DPM, Hyrich KL. Fagerli KM, et al. Among authors: symmons dpm. Rheumatology (Oxford). 2019 Jan 1;58(1):80-85. doi: 10.1093/rheumatology/key241. Rheumatology (Oxford). 2019. PMID: 30137485 Free PMC article.
Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).
Sergeant JC, Hyrich KL, Anderson J, Kopec-Harding K, Hope HF, Symmons DPM; RAMS Co-Investigators; Barton A, Verstappen SMM. Sergeant JC, et al. Among authors: symmons dpm. Arthritis Res Ther. 2018 Jul 13;20(1):147. doi: 10.1186/s13075-018-1645-5. Arthritis Res Ther. 2018. PMID: 30005689 Free PMC article.
Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review.
Gwinnutt JM, Sharp CA, Symmons DPM, Lunt M, Verstappen SMM. Gwinnutt JM, et al. Among authors: symmons dpm. Semin Arthritis Rheum. 2018 Dec;48(3):384-398. doi: 10.1016/j.semarthrit.2018.03.004. Epub 2018 Mar 15. Semin Arthritis Rheum. 2018. PMID: 29680162 Free PMC article.
316 results